- Report
- June 2026
- 413 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- January 2026
- 489 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- November 2025
- 367 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- March 2026
- 220 Pages
Global
From €4305EUR$4,799USD£3,680GBP
- Report
- June 2026
- 555 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- June 2026
- 328 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- April 2026
- 511 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- September 2025
- 313 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- July 2026
- 250 Pages
Global
From €4028EUR$4,490USD£3,443GBP
- Report
- June 2026
- 200 Pages
Global
From €2682EUR$2,990USD£2,293GBP
- Report
- May 2026
- 150 Pages
Global
From €5337EUR$5,950USD£4,563GBP
- Report
- August 2026
- 187 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- January 2026
- 199 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 191 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 187 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 190 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 192 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 181 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 185 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2026
- 189 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more